Pharma bribery corrupts health care, puts patients at risk, new review warns

from U.S. Right to Know articles · host Pamela Ferdinand

Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.

Episode metadata supplied by the publisher feed · Published Mar 25, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Pharma bribery corrupts health care, puts patients at risk, new review warns

0:00 30:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

California’s solution for senior health care hides in plain sight

Mar 22, 2026 ·14m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of U.S. Right to Know articles?

This episode is 30 minutes long.

When was this U.S. Right to Know articles episode published?

This episode was published on March 25, 2026.

Can I download this U.S. Right to Know articles episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!